Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus

Overview of attention for article published in Digestive Diseases and Sciences, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Dimensions has found 123 publications that cite this research output.

Article in Biomedicine & Pharmacotherapy (April 2024)

Article in Frontiers in Nutrition (March 2024)

Article in Current Opinion in Lipidology (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.